Literature DB >> 24701444

Depression and type 2 diabetes in developed and developing countries.

Salma Bensbaa1, Chadya Araab2, Saïd Boujraf3, Farida Ajdi1.   

Abstract

Entities:  

Year:  2014        PMID: 24701444      PMCID: PMC3968719          DOI: 10.4103/2230-8210.126592

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


× No keyword cloud information.
Sir, Diabetes patients are more exposed to depression. This association might yield higher rates of mortality, morbidity and costs of health-care.[1] The world evaluation of depression prevalence in diabetes patients seems to vary according to the prosperity and health-care system of each country.[2] Hence, what are the factors of impact on the gap of depression rate within type 2 diabetes (T2D) in developing and developed countries? What are the care possibilities to reduce the depression rate in developing countries compared with developed countries? To answer this question, we achieved a transversal study in the University Hospital of Fez, Morocco. The study included 142 T2D patients. The average age of patients was 56.68-year-old, without significant difference in gender ration. The depression prevalence in our patients was 33.1%. Factors connected to the depression of MoroccanT2D are summarized in Table 1.
Table 1

Risk factors related to depression in Moroccan T2D patients

Risk factors related to depression in Moroccan T2D patients The prevalence of T2D was significantly higher compared with the general population. It varies between 12% and 44%. Indeed, the prevalence of T2D is lower in western countries; it is elevated in developing countries.[34] The literature review revealed that depression of T2D patients is mostly associated to unchangeable factors such as the duration of evolution and arterial hypertension, which are common factors in developed and developing countries.[3] Besides, depression of T2D patients is strongly connected the low educational level of patients, a lack of social security. These two factors are dominant in developing countries.[5] Indeed, in developing countries factors such as lack of social, lower educational level, strong poverty level and resources and financial difficulties constitute the economical outline of stress responsible for insecurity feeling toward chronic disease such T2D. Furthermore, the health-care of T2D patients might require referencing the patients to specialist that might be involved including psychiatrists, which are not available geographically within joint distance for many patients. Therefore, we do consider the challenge of treatment approach of T2D patients. It is necessary to integrate diabetes within a framework of biopsychosocial and political approach. We suggest integrating T2D patient in coordinated multidisciplinary strategy of health-care. This should include a health-care staff sensitive to the screening and managing the psychological state T2D patients and risk factors of the depression. This could be achieved through improving the general life condition including eradicating illiteracy and generalizing the social security for forward improvement of access to health-care.
  4 in total

1.  Depression and all-cause and coronary heart disease mortality among adults with and without diabetes.

Authors:  Leonard E Egede; Paul J Nietert; Deyi Zheng
Journal:  Diabetes Care       Date:  2005-06       Impact factor: 19.112

2.  Common mental disorders associated with 2-year diabetes incidence: the Netherlands Study of Depression and Anxiety (NESDA).

Authors:  Evan Atlantis; Nicole Vogelzangs; Kara Cashman; Brenda J W H Penninx
Journal:  J Affect Disord       Date:  2012-10       Impact factor: 4.839

3.  Correlates of anxiety and depression among patients with type 2 diabetes mellitus.

Authors:  Yatan Pal Singh Balhara; Rajesh Sagar
Journal:  Indian J Endocrinol Metab       Date:  2011-07

Review 4.  Depression and type 2 diabetes over the lifespan: a meta-analysis.

Authors:  Briana Mezuk; William W Eaton; Sandra Albrecht; Sherita Hill Golden
Journal:  Diabetes Care       Date:  2008-12       Impact factor: 17.152

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.